Acquired Bleeding Disorder — Recombinant Factor VIIa in Acute Intracerebral Haemorrhage
Citation(s)
Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven®/Niastase®) in Acute Intracerebral Haemorrhage